Anti-IL6ST DNA-encoded mAb (DMAb), pVAX1 (DMAb-1401-YY)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-IL6ST DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • IL6ST
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.

Target

  • Entrez Gene ID
  • 3572
Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-0165-YY CBYY-0695 Mouse Human IgG2a Recognizes the human CD130 cell surface antigen, a 130kD glycoprotein that is a part of cell surface receptor complexes for cytokines including IL-6, LIF, OSM and IL-11
DMAb-0166-YY CBYY-0696 Mouse Human IgG1 Mouse myeloma cell line NS0-derived recombinant rat gp130 Gln23-Glu618 (predicted)
DMAb-3769CQ CBXC-1864 Mouse IgG1
DMAb-3770CQ CBXC-1856 Mouse IgG2a
DMAb-3771CQ CBXC-1841 Mouse IgG2b
DMAb-3772CQ CBXC-1844 Mouse IgG1
DMAb-3773CQ CBXC-1853 Mouse IgG1
DMAb-3994-FY CBFYC-2777 Rat Mouse IgG2 Mouse recombinant protein gp-130
DMAb-3995-FY CBFYC-2778 Rat Mouse IgG2a Mouse myeloma cell line NS0-derived recombinant mouse gp130 Gln23-Glu617 (predicted)
DMAb-3996-FY CBFYC-2779 Mouse Human IgG1 Recombinant human gp130 extracellular domain
DMAb-3511-FY CBFYH-2594 Mouse Human IgG1
DMAb-3508-FY CBFYH-2592 Rat Mouse IgG2a Mouse myeloma cell line NS0-derived recombinant mouse gp130, Gln23-Glu617
DMAb-3504-FY CBFYH-3280 Mouse Human IgG1 Human CD130
DMAb-3519-FY CBFYH-2593 Mouse Rat IgG1 Mouse myeloma cell line NS0-derived recombinant rat gp130, Gln23-Glu618
DMAb-3631-FY CBFYH-2590 Rat Mouse IgG2a CD130 transfectant mouse cell
DMAb-3632-FY CBFYH-2591 Mouse Human IgG1 Sf 21-derived recombinant human gp130 extracellular domain, Leu24-Glu619

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-IL6ST DNA-encoded mAb (DMAb), pVAX1 (DMAb-1401-YY). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.